Episode 30
We’re joined by Vered Caplan, CEO of Orgenesis, as she shares her insights into the cell and gene therapy sector.
With a background in engineering and business, Vered found her passion in the cell and gene therapy industry. She founded Orgenesis with a mission to bring innovative therapies to patients, by leveraging cutting-edge science to create a more efficient, scalable, and affordable pathway to patients.
In this episode, Vered discusses:
- The need for greater adoption of technology to overcome manufacturing challenges of advanced therapies
- Why digital is the key to tailoring manufacturing processes to the individual needs of patients
- How industry partnerships support the scalability of therapy products
Further information